Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HEPA - Hepion Pharmaceuticals CEO Robert Foster - Dash To Beat NASH

HEPA - Hepion Pharmaceuticals CEO Robert Foster - Dash To Beat NASH

Hepion Pharmaceuticals Inc.
  • Hepion Pharmaceuticals CEO Robert Foster speaks about the global non-alcoholic steatohepatitis (NASH) endemic and the race to find a cure.
  • How Hepion's drug Rencofilstat (CRV431) targets NASH and in a more recent study, has potential to treat liver cancer.
  • What is in store for the biotech sector in 2022.

For further details see:

Hepion Pharmaceuticals CEO Robert Foster - Dash To Beat NASH
Stock Information
Company Name: Hepion Pharmaceuticals Inc.
Stock Symbol: HEPA
Market: NASDAQ
Website: hepionpharma.com
Menu
HEPA HEPA Quote HEPA Short HEPA News HEPA Articles HEPA Message Board
Get HEPA Alerts

News, Short Squeeze, Breakout and More Instantly...